RELL2 and breast carcinoma: RELL2 possesses anti-tumorigenic activities against the breast cancer cell lines 4T1 and 231; treatment of these cell lines with the saponin PPVI upregulates RELL2 expression by relieving the inhibition of mir-18a on RELL2 expression [62].